Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study
Axel Bauer, Andrzej Lubiński(Medical University of Lodz), Alexander Steger(TUM Klinikum), Simon Schlögl(Universitätsmedizin Göttingen), Lukas von Stülpnagel(Innsbruck Medical University), Bert Vandenberk(KU Leuven), Thomas Reinhold(Humboldt-Universität zu Berlin), Marc A. Vos(University Medical Center Utrecht), Stefan Kääb(German Centre for Cardiovascular Research), Ανδρέας Κατσιμάρδος, Tobias Tichelbäcker(University of Cologne), Leonard Bergau, Lars Lüthje(Universitätsmedizin Göttingen), Markus Harden(Universitätsmedizin Göttingen), Heikki V. Huikuri(Oulu University Hospital), Konstantinos D. Rizas(German Centre for Cardiovascular Research), Andrezej Lubinski(Medical University of Lodz), Wolfgang Hamm(German Centre for Cardiovascular Research), Pascal Muñoz-Exposito, Markus Zabel(Universitätsmedizin Göttingen), Tim Friede(Universitätsmedizin Göttingen), Róbert Hatala, Krapinske Toplice, Dimitrios Katsaras, Michael Dommasch(TUM Klinikum), Mathias Klemm(German Centre for Cardiovascular Research), Katerina Hnatkova, Georg Schmidt(Technical University of Munich), Marek Malík(Riphah International University), Rik Willems(KU Leuven), Christian Sticherling(University Hospital of Basel), Joachim Seegers(University Hospital Regensburg), Zoltán Salló, Helge Haarmann, Péter Perge, Gábor Széplaki(Royal College of Surgeons in Ireland), Martin Svetlošák(Slovak Medical University), Béla Merkely(Semmelweis University), Magdalena Klinika, Stefan N. Willich(Humboldt-Universität zu Berlin), Panagiota Flevari(University General Hospital Attikon), Gerd Hasenfuß(Universitätsmedizin Göttingen), Panayota Flevari(University General Hospital Attikon), Aleksandra Kirova
Cited by 65
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction
|New England Journal of Medicine|2004|1.5k
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions
|European Journal of Heart Failure|2016|781